Table 1 Demographic and metabolic characteristics of the study samples between longevity and controls

Cardiovascular disease(N)

17

0

<.001

 Never

295

420

<.001

 Former

12

15

 Current

0

51

  ≤ 10

0

35

-

  ≥ 11

0

31

 1–3 times/month

6

10

0.772

 1–2 times/week

23

44

 3–4 times/week

8

20

 Nearly 1 time/day

5

6

 Antidyslipidemic

0

0

-

 Antihypertensive

2

0

 Antidiabetic

0

0

Gender(M/F)(N)

81/226

301/185

<.001

Age (Median(INR))

94(91–98)

48(45–49)

<.001

Height (Median(INR))

145.0(140.0–151.0)

164.5(158.0–169.5)

<.001

Weight (Median(INR))

38(34–45)

66(58–72)

<.001

BMI (Median(INR))

18.35(16.41–20.93)

24.11(22.57–26.00)

<.001

SBP (Median(INR))

146(132–160)

120(110–130)

<.001

DBP (Median(INR))

80(72–90)

76(70–84)

<.001

WC (Median(INR))

71.0(65.0–78.0)

80.5(75.0–86.0)

<.001

FPG (Median(INR))

5.08(4.30–6.16)

4.89(4.47–5.24)

<.001

TG (Median(INR))

1.08(0.77–1.55)

1.52(1.22–1.86)

0.002

HDL-C (Median(INR))

1.40(1.10–1.81)

1.46(1.30–1.68)

0.766